Israeli health technology start-up Tyto Care has raised $25m in new investment to continue its expansion into the China market. The company, which specialises in telehealth products, launched a range of devices in the China early last year, including a digital connected stethoscope that was cleared by the Food and Drug Administration in 2016 for use in the country. The latest round of funding was led by US's Ping An Insurance Group and included a number of returning investors. Tyto CEO Dedi Gilad said the cash injection was a signal of the market's trust in the potential of telehealth.
Israeli health technology start-up Tyto Care has raised $25m in new investment to continue its expansion into the US market. The company, which specialises in telehealth products, launched a range of devices in the US early last year, including a digital connected stethoscope that was cleared by the Food and Drug Administration in 2016 for use in the country. The latest round of funding was led by China's Ping An Insurance Group and included a number of returning investors. Tyto CEO Dedi Gilad said the cash injection was a signal of the market's trust in the potential of telehealth.